4th LISBON VASCULAR FORUM 4º FORUM VASCULAR DE LISBOA LISBON MARRIOTT HOTEL 13 and 14 DECEMBER 2013 PROGRAMA PRELIMINAR PRELIMINARY PROGRAM SERVIÇO DE CIRURGIA VASCULAR / CLÍNICA UNIVERSITÁRIA HOSPITAL DE SANTA MARIA CENTRO HOSPITALAR LISBOA NORTE FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA INSTITUTO CARDIOVASCULAR DE LISBOA 1
13 DEZEMBRO SEXTA-FEIRA 13 TH DECEMBER FRIDAY SESSÃO 1 SESSION 1 CRITICAL LIMB ISCHEMIA NEW PERSPECTIVES AND CONSENSUS FOR CLINICAL PRACTICE PRESIDENTES CHAIRPERSONS: Luís Mota Capitão and Luís Gardete Correia Ivone Silva, Diogo Cunha e Sá,Teresa Vieira 14.30 14.40 Portugal 2013 The Challenge of Diabetes and Limb Ischemia João Raposo 14.40 14.50 Critical Limb Ischaemia: a global problem. Present controversies Nicos Angelides 14.50 15.00 The case for open revascularization why and when? F. Spinelli 15.00 15.10 The case for endovascular revascularization as first option tba 15.10 15.20 CLI Have we improved clinical outcomes? Ruy Fernandes e Fernandes 15.20 15.30 Are there new developments on angiogenesis? A new perspective Augusto Ministro 15.30 15.40 Diabetic Foot Clinic our approach and how we improved Outcomes Joana Martins 15.40 16.00 DISCUSSION 16.00 16.20 COFFEE BREAK AND VISIT THE TECHNICAL EXHIBITION 2
SESSÃO 2 SESSION 2 CRITICAL LIMB ISCHEMIA (CONT.) Albuquerque de Matos e Alexandre Diniz Nuno Meireles, Gabriel Anacleto, Rui Machado 16.20 16.30 The Portuguese Association for Diabetics A successful story Luís Gardete Correia 16.30 16.40 Critical Limb Ischemia Information from National Registries and European Cooperation Martin Bjork 16.40 16.50 Critical Limb Ischemia in Brazil My way! Arno von Ristow 16.50 17.00 Quality Assessment a major need in times of financial constrains. How to implement it? Paulo Sousa 17.00 17.10 Do we need a fast track access ( via verde) for diabetics with lower limb ischemia? How to do it? José Manuel Boavida 17.10 17.20 Care for CLI the need for a new model of integrated care J. Fernandes e Fernandes 17.20 17.30 Vascular Care Reorganization the London model tba 17.30 17.50 DISCUSSION SESSÃO 3 SESSION 3 Silva Nunes e Pereira Albino 17.50 18.15 Presentation of Clinical Cases and Discussion 3
18.20 18.45 OPENING CEREMONY 19.45 COACHES LEAVE FOR DINNER 14TH DEZEMBRO SÁBADO 14 TH DECEMBER SATURDAY SESSÃO 4 SESSION 4 CEREBROVASCULAR DISEASE CONSENSUS FOR CLINICAL PRACTICE PRESIDENTES CHAIRPERSONS: Isabel Cássio and José França Celso Carrilho, Carlos Martins, Paulo Baptista 09.00 09.10 Early carotid endarterectomy after TIA/Stroke is the best way to prevent stroke L. Mendes Pedro 09.10 09.20 Carotid Endarterectomy Which Technique? Does it matter? Domenico Palumbo 09.20 09.30 Is Carotid Stent a safe option and when I do it? Chris Liapis 09.30 09.40 Safety for the brain which is the best option and why? Laura Cappoccia 09.40 09.50 How can we identify the active carotid plaque How I do it Bruno Gossetti 09.50 10.00 Management of carotid stenosis risk adjusted or surgeon s whim? Does evidence matter? Carlo Setacci 4
10.00 10.10 From RCT S to the real world Lessons for today s practice. H. Eckstein 10.10 10.20 Management of Carotid Disease in the USA what is new? Frank Veith 10.20 10.40 DISCUSSION 10.40 11.00 COFFEE BREAK AND VISIT TECHNICAL EXHIBITION SESSÃO 5 SESSION 5 VENOUS DISEASE CONSENSUS FOR CLINICAL PRACTICE PRESIDENTES CHAIRPERSONS: Alexandra Canedo and Amílcar Mesquita Angélica Damião, Leonor Vasconcelos, Pedro Brandão 11.00 11.10 How should we measure success in the the treatment of Chronic Venous Insufficiency? A. Mansilha 11.10 11.20 What is new in the management of DVT? Implications for clinical practice A. Jawien 11.20 11.30 Management of Varicose Veins Options and Recommendations Allun Davis 11.30 11.40 Is there a place for deep venous reconstruction? When and How? Martin Bjork 11.40 12.00 DISCUSSION SESSÃO 6 SESSION 6 CONSENSUS FOR CLINICAL PRACTICE Rui Almeida e Duarte Medeiros Ana Evangelista, Emilia Ferreira, Manuel Fonseca 12.00 12.10 Management of Popliteal Aneurysms what is the evidence? Martin Bjork 5
12.10 12.20 Mesenteric ischemia only endovascular? Nuno V. Dias 12.20 12.30 Can we improve selection of patients for renal revascularization and what to do? New developments? George Hamilton 12.300 12.45 DISCUSSION SESSÃO 7 SESSION 7 CHALLENGING CLINICAL CASES PRESIDENTES CHAIRPERSON: Maria José Ferreira and R. Roncon de Albuquerque Sérgio Sampaio, Daniel Brandão, João Silva e Castro 12.45 13.30 3 PRESENTATIONS + 2 DISCUSSION FOR EACH CASE 13.30 14.30 WORKING LUNCH TECHNICAL EXHIBITION SESSÃO 8 SESSION 8 AORTIC ANEURYSMS AND DISSECTION Duarte Medeiros and José Teixeira Gonçalo Sobrinho, António Assunção, Gil Marques 14.30 14.40 Aortic aneurismal disease diffuse or segmental disease? What is the evidence from basic science? Michael Jacobs 14.40 14.50 Strategies for follow-up after EVAR and TEVAR- should they be the same? Nuno V. Dias 15.00 15.10 Is life follow-up after EVAR required? When not? F. Bastos Gonçalves 15.10 15.20 Iliac dilatation in EVAR how should it be treated? Ruy Fernandes e Fernandes 15.20 15.30 EVAR for challenging anatomies are late results favorable? H. Verhagen 6
15.30 15.40 How short can we accept proximal necks and when should we select fenestrated endografts? Eric Verhoeven 15.40 15.50 Is there a place for open surgery for AAA? When do I do it? Arno von Ristow 15.50 16.10 DISCUSSION 16.10 16.30 COFFEE BREAK AND VISIT TECHNICAL EXHIBITION SESSÃO 9 SESSION 9 AORTIC ANEURYSMS AND DISSECTION (cont) Carlos Vaquero Puerta and João de Castro Óscar Gonçalves, José Daniel Menezes, Mário Macedo 16.30 16.40 Do single centre experience match the RCT s results? What should influence management decision? J. Fernandes e Fernandes 16.40 16.50 Quality of life following EVAR does it make a difference? Rui Machado 16.50 17.00 DEBATE Open surgery is redundant for AAA all can and should be treated by endovascular surgery For (5 ): Eric Verhoeven Against(5 ) Roberto Chiesa 17.05 17.10 The American perspective Frank Veith 17.10 17.20 Concomitant thoracic and abdominal aortic aneurysms what is the evidence to optimize management? Luís Mendes Pedro 17.20 17.30 Thoracic aortic aneurysms determinants of endoprosthesis selection Vicente Riambau 7
17.30 17.40 TEE for thoracic aortic deployment of endograft an advantage Franco Grego 17.40 17.50 New information for the management of aortic dissections Jan Brunkval 17.50 18.00 Can we reduce the need for late reinterventions following repair of tpe A aortic dissection? Ângelo Nobre 18.00 18.10 Open surgery for TAA determinants of success Michael Jacobs 18.10 18.20 Endovascular surgery for TAA where do we stand today and how far can we go? Eric Verhoeven 18.20 18.30 TAA after chronic aortic dissection what is my strategy? Roberto Chiesa 18.30 19.00 DISCUSSION 8
COMISSÃO ORGANIZADORA J. Fernandes e Fernandes Luís Mendes Pedro Paulo de Sousa Ruy Fernandes e Fernandes Secretariado Faculdade de Medicina da Universidade de Lisboa Email: rguimaraes@fm.ul.pt Instituto Cardiovascular de Lisboa Email: lsilva@icvl.pt Site: www.icvl.pt 9